Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Nupathe, Inc.

Home Clinical Trial Sponsors and OrganizationsNupathe, Inc.

Nupathe, Inc.

ACTIVE

41 Moores Rd, 宾夕法尼亚州切斯特县, Pennsylvania, United Stateswww.nupathe.comSubsidiary14 employeesEstablished: 2005-01-01

Part of Teva Pharmaceutical Industries Ltd.

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

8

0 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

2005

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 1

5

62.5%

Phase 3

3

37.5%

Trial Status Distribution

Completed

8

100.0%

Clinical Trials

Trials sponsored by this organization (8)

Safety, Pharmacokinetic, and Tolerability Study of Zecuity® in Adolescent Subjects With a History of Acute Migraine

Aug 201337 participants

Compare PK and Bioavailability of 2 NP101 Patches With Oral Imitrex in Healthy Adults

Dec 200963 participants

An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over Twelve Months

Feb 2009514 participants

An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over 12 Months

Jan 2009198 participants

The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine

Jan 2009530 participants

Phase I, Open Label, Single-Dose, Four Way Crossover Study to Compare the PK of NP101 With Oral Imitrex® (50mg) in Migraine Subjects During an Acute Migraine Attack and During a Non-Migraine Period

Nov 200823 participants

Phase I Open Label Single-Dose Study to Compare the Pharmacokinetics of NP101 Healthy Volunteers

Jun 20084 participants

Phase I Study to Compare NP101(Sumatriptan Iontophoretic Transdermal Patch) With Three Formulations of Imitrex®

Nov 200725 participants

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials8
Approvals
News

Back to Organizations